Impact of Continuous Glucose Monitoring (CGM) on Glycemic Control and Acute Complications in Type 2 Diabetes (T2D) in the Veterans Health Administration (VHA)

被引：0
|
作者：
Reaven, Peter
Newell, Michelle
Rivas, Salvador
Zhou, Xinkai
Norman, Gregory J.
Zhou, Jin
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1138-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1138-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Gender differences in glycemic control in African-American (AA) children with type 2 diabetes (T2D)
    Mokhashi, M
    Rao, J
    Vargas, A
    Stuart-Chalew
    DIABETES, 2003, 52 : A404 - A404
  • [42] Effects of Dapagliflozin (DAPA), a Sodium Glucose Cotransporter 2 Inhibitor, on 24-Hour Glycemic Control in Patients with Type 2 Diabetes (T2D)
    Henry, Robert R.
    Strange, Poul
    Zhou, Rong
    Zhuplatov, Sergey B.
    Mansfield, Traci
    Klein, David
    Katz, Arie
    DIABETES, 2016, 65 : A311 - A311
  • [43] Associations of Growth Hormone (GH) Mediators with Loss of Glycemic Control in Youth with Type 2 Diabetes (T2D)
    Lu, Chang
    Wolfs, Danielle
    El Ghormli, Laure
    Laffel, Lori M.
    Patti, Mary-Elizabeth
    Isganaitis, Elvira M.
    DIABETES, 2023, 72
  • [44] Pioglitazone (PIO) is superior to gliclazide (GLIC) in sustaining glycemic control in patients with type 2 diabetes (T2D)
    Tan, M
    Johns, D
    Urquhart, R
    Voet, B
    Mariz, S
    Mattoo, V
    DIABETES, 2004, 53 : A147 - A147
  • [45] Predictive Factors for Achieving Glycemic Control in People with Type 2 Diabetes (T2D) in Real Clinical Practice
    Chaudhury, Tirthankar
    Al Mansari, Abdulqawi
    Obeid, Youssef
    Islam, Najamul
    Fariduddin, Mohammed
    Hassoun, Ahmed
    Djaballah, Khier
    Malek, Mojtaba
    DIABETES, 2017, 66 : A615 - A616
  • [46] Are Morning Fasting Glucose and A1c the Best Measures for Glycemic Control in Patients with Type 2 Diabetes (T2D) on Metformin Monotherapy?
    Strange, Poul
    Frias, Juan P.
    Miller, Michael
    Mansfield, Traci
    Ruggles, James
    DIABETES, 2017, 66 : A241 - A241
  • [47] Impact of Continuous Glucose Monitoring on Glycemic Control in Adults with Type 1 Diabetes: A Longitudinal Study
    Kim, S.
    Kim, J. H.
    Kim, G.
    Cho, S. H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [48] The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes
    Idrees, T.
    Zabala, Z. E.
    Moreno, E. M.
    Gerges, A.
    Urrutia, M. A.
    Ruiz, J. G.
    Vaughan, C.
    Vellanki, P.
    Pasquel, F. J.
    Peng, L.
    Umpierrez, G. E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [49] Continuous Glucose Monitoring and Glycemic Control in People With Type 2 Diabetes: Real-World Study
    Maldonado Reyes, Alondra Nicole
    Lugo de la Cruz, Arely Joseline
    Ramirez Frias, Cecilia Nohemi
    Mirafuentes Rios, Martha Evelyn
    Aguilar Barrera, Eliud Salvador
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S50 - S50
  • [50] Glycemic Control with Once-Weekly Basal Insulin Fc (BIF) in Persons with Type 2 Diabetes Mellitus (T2DM) Using Continuous Glucose Monitoring (CGM) in a Phase 2 Study
    Kazda, Christof M.
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Wullenweber, Paula
    Haupt, Axel
    Frias, Juan P.
    DIABETES, 2021, 70
12345